Topics
Glioblastoma | Treatment | Pharmacotherapy | Antiemetic drugs
Home > Publications > Topics > Glioblastoma > Treatment > Pharmacotherapy > Antiemetic drugs
Kast RE, Marques Vieira B, Barros da Silva E Jr.
A
New Adjuvant Treatment for Glioblastoma Using Aprepitant,
Vortioxetine, Roflumilast and Olanzapine: The AVRO Regimen.
Int
J Mol Sci. 2025 Jun 26;26(13):6158. doi:
10.3390/ijms26136158. PMID:
40649933. Review. ˍ
Affronti ML, Patel MP, Severance
EK, Loughlin C, Bradbury C, Herndon JE, Boyd K, Lipp ES, Friedman
HS, Desjardins A, Johnson MO, Peters KB.
Phase
II randomized glioma study to evaluate efficacy and satisfaction
of rolapitant plus ondansetron in preventing
chemoradiation-induced nausea and vomiting.
Neurooncol
Pract. 2025 Jan
28;12(4):618-630. doi:
10.1093/nop/npaf014. PMID:
40814434. Interventional
study˰ Meeting
abstract.
ˍ
AI
Overview